Ballentine Partners’s HealthEquity HQY Stock Holding History

Ballentine Partners’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,392	Closed	-$211K	–	1025
2025 Q1	$211K	Buy	2,392 +15	+0.6%	+$1.54K	﹤0.01%	780
2024 Q4	$228K	Buy	+2,377	New	+$222K	﹤0.01%	730

Other funds holding HQY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ballentine Partners's HQY Position: Q2 2025 in Review

Ballentine Partners sold out of HealthEquity (HQY) in Q2 2025, closing a stake of 2,392 shares — an estimated $211K sold.

Ballentine Partners first reported a position in HQY in Q4 2024 and held it in 2 quarters. The position peaked at $228K in Q4 2024. 486 funds tracked by Wall St. Rank hold HQY as of Q2 2025.

Ballentine Partners reported no remaining HealthEquity position as of Q2 2025 after selling out during the quarter.
Ballentine Partners sold 2,392 HealthEquity shares in Q2 2025, an estimated $211K.
Ballentine Partners first reported a position in HealthEquity in Q4 2024 and held it in 2 quarters.
Ballentine Partners's HealthEquity position peaked at $228K in Q4 2024.
486 funds tracked by Wall St. Rank held HealthEquity as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.